|
|
DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriChip Corporation
(Nasdaq:CHIP - News), a provider of RFID systems for healthcare
and patient-related needs, announced today that the Company’s
wholly-owned subsidiary, Xmark, recently completed a sale of
an infant protection system in the state of Ohio, where Xmark’s
infant protection systems are now installed in more than half
of all birthing facilities. This install base features systems
sold under the Company’s HUGS® brand. Xmark’s infant protection systems are designed to prevent infant abductions and inadvertent child mismatching. The main component of the systems is a wearable RFID tag that is assigned to child and mother following birth. Monitors positioned throughout the hospital detect the integrity of the tags and location of the child. If a newborn is removed from the ward, if the tag is lifted from the baby’s skin or if the ankle strap is compromised, the system immediately triggers an alarm, alerting hospital security to the situation. Xmark infant protection systems also protect against mismatching events by affixing matching RFID tags to mother and child. If the mother is given the wrong child, the RFID tag detects the mismatch and activates an audible alarm. For more information on Xmark’s products, please contact 1-866-55–XMARK or email sales@xmark.com. Additional information can be found online at www.xmark.com. About Xmark Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip Corporation. For over 25 years, Xmark Corporation has provided Radio Frequency Identification (RFID) solutions to identify, locate, and protect people and assets in healthcare environments. Its market-leading infant protection, wander prevention, personal duress, and asset tracking applications are trusted by over 5,000 healthcare institutions worldwide to keep individuals safe. Xmark products are installed and serviced through an international network of authorized dealers, backed by a dedicated technical services department at Xmark. All aspects of Xmark’s business are certified to the ISO 9001 quality standard. About VeriChip VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. VeriChip Corporation is majority-owned by Applied Digital Solutions Inc. (Nasdaq:ADSX - News), which also owns a majority position in Digital Angel Corporation (AMEX:DOC - News). Digital Angel, a leader in RFID and GPS technologies, owns the patent on the human implantable, passive RFID microchip and manufactures it for VeriChip. For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com. Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Contact: |
|
|
|